P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY

• Loïc Ysebaert,
• Xavier Troussard,
• Vincent Levy,
• Ronan Le Calloch,
• Romain Guieze,
• Kamel Laribi,
• Stephane Lepretre,
• Anne Sophie Michallet,
• Véronique Leblond,
• Pierre Feugier,
• Elhem Lahjibi,
• Julien Ramier,
• Alain Delmer

Affiliations

Loïc Ysebaert

1 IUCT Oncopole, Hematology, Toulouse, France

Xavier Troussard

2 Caen University Hospital, Hematology, Caen, France

Vincent Levy

3 Avicenne Hospital, Hematology, Bobigny, France

Ronan Le Calloch

4 Hospital Center, Quimper, Hematology, Quimper, France

Romain Guieze

5 Estaing University Hospital, Hematology, Clermont-Ferrand, France

Kamel Laribi

6 Le Mans Hospital Center, Hematology, Le Mans, France

Stephane Lepretre

7 Henri Becquerel Center, Hematology, Rouen, France

Anne Sophie Michallet

8 Cancer Research Center Lyon, Hematology, Lyon, France

Véronique Leblond

9 Pitié-Salpêtrière University Hospital, Hematology, Paris, France

Pierre Feugier

10 Nancy University Hospital, Hematology, Vandœuvre-lès-Nancy, France

Elhem Lahjibi

11 AbbVie, Medical Affairs, Rungis, France

Julien Ramier

11 AbbVie, Medical Affairs, Rungis, France

Alain Delmer

12 Reims University Hospital, Hematology, Reims, France